Pubblicazioni

Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome. A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patients

2021 - INTERNATIONAL JOURNAL OF CARDIOLOGY

Claassens, D. M. F.; Gimbel, M. E.; Bergmeijer, T. O.; Vos, G. J. A.; Hermanides, R. S.; van der Harst, P.; Barbato, E.; Morisco, C.; Tjon Joe Gin, R. M.; de Vrey, E. A.; Heestermans, T. A. C. M.; Jukema, J. W.; von Birgelen, C.; Waalewijn, R. A.; Hofma, S. H.; den Hartog, F. R.; Voskuil, M.; van't Hof, A. W. J.; Asselbergs, F. W.; Mosterd, A.; Herrman, J. -P. R.; Dewilde, W.; Mahmoodi, B. K.; Deneer, V. H. M.; ten Berg, J. M.

Comparison of therapy with ticagrelor, prasugrel or high clopidogrel dose in pci patients with high on treatment platelet reactivity and genotype variation. triplete reset trial

2015 - INTERNATIONAL JOURNAL OF CARDIOLOGY

Sardella, Gennaro; Calcagno, Simone; Mancone, Massimo; Lucisano, Luigi; Pennacchi, Mauro; Stio, Rocco Edoardo; Placentino, Filippo; Di Roma, Angelo; Cavallo, Erika; Palmirotta, Raffaele; Guadagni, Fiorella; Fedele, Francesco

Impact of greater than 12-month dual antiplatelet therapy duration on mortality: Drug-specific or a class-effect? A meta-analysis

2015 - INTERNATIONAL JOURNAL OF CARDIOLOGY

Costa, Francesco; Adamo, Marianna; Ariotti, Sara; Navarese, Eliano Pio; Biondi-Zoccai, Giuseppe; Valgimigli, Marco